Building Capacity for Active Surveillance of Vaccine Adverse Events in Low and Middle-Income Countries
Por:
Sturkenboom, M, Perez-Vilar, S, Weibel, D, Black, S, Maure, C, Castro, J, Bravo-Alcantara, P, Dodd, C, Romio, S, de Ridder, M, Nakato, S, Molina, H, Elango, V and Zuber, P
Publicada:
1 ago 2017
Resumen:
Filiaciones:
Sturkenboom, M:
Erasmus Univ, Med Ctr, Rotterdam, Netherlands
Vaccine GRID Fdn, Basel, Switzerland
:
Erasmus Univ, Med Ctr, Rotterdam, Netherlands
FISABIO, Fdn Fomento Invest Sanitaria & Biomed Comunitat, Valencia, Spain
Weibel, D:
Erasmus Univ, Med Ctr, Rotterdam, Netherlands
Vaccine GRID Fdn, Basel, Switzerland
Black, S:
Vaccine GRID Fdn, Basel, Switzerland
Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
Maure, C:
WHO, Geneva, Switzerland
Castro, J:
WHO, Pan Amer Hlth Org, Washington, DC USA
Bravo-Alcantara, P:
WHO, Pan Amer Hlth Org, Washington, DC USA
Dodd, C:
Erasmus Univ, Med Ctr, Rotterdam, Netherlands
Romio, S:
Erasmus Univ, Med Ctr, Rotterdam, Netherlands
Univ Milano Bicocca, Milan, Italy
de Ridder, M:
Erasmus Univ, Med Ctr, Rotterdam, Netherlands
Nakato, S:
Erasmus Univ, Med Ctr, Rotterdam, Netherlands
Molina, H:
WHO, Pan Amer Hlth Org, Washington, DC USA
Elango, V:
WHO, Geneva, Switzerland
Zuber, P:
WHO, Geneva, Switzerland
|